- Walgreens expanding scope of retail pharmacy experience and services heading into fiscal 2014
- Walgreens firing on all cylinders as chain realizes a total comp sales increase of 5.4% for its first quarter
- Bloomberg: Greg Wasson joins thought leaders to discuss the state of health care in the United States
- GSK, Walgreens launch Sponsorship to Quit, a free online quit-smoking program
- Walgreens' corporate operations VP tapped to lead health care for Boots in U.K. and Ireland
CHICAGO — Standard & Poor's cut its outlook on Walgreens to negative from stable, citing the lack of progress in the drug store chain's negotiations with Express Scripts, according to a MarketWatch report published Thursday.
S&P noted that the loss of the Express Scripts contract will result in a meaningful revenue and profit decline in fiscal 2012 in initiating its outlook adjustment.
However, S&P did affirm its ratings on the company, including an 'A' corporate credit rating, MarketWatch reported.
Shares of Walgreens were down 18 cents to $32.97 in mid-morning trading.